US Broker Ratings

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the development and manufacturing of medical devices. Headquartered in Plano, Texas, with operations extending to Puerto..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Evaluating the Healthcare Innovator’s Growth Potential

Krystal Biotech, Inc. (NASDAQ: KRYS), a trailblazer in the biotechnology sector, continues to capture investor interest with its innovative genetic medicines targeting diseases with high unmet medical needs. With a..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Potential Amidst Market Dynamics

Elanco Animal Health Incorporated (NYSE: ELAN) has captured the attention of investors with its strategic position in the healthcare sector, specifically within the niche of drug manufacturers specializing in animal..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring Growth Potential Amid a 3.39% Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO), a biotechnology firm from the healthcare sector, is making waves with its innovative approach to treating metabolic diseases. As investors look to capitalize on the..

Waystar Holding Corp. (WAY) Stock Analysis: A 55.9% Upside Potential in Healthcare Tech

Waystar Holding Corp. (WAY), a key player in the healthcare information services sector, is attracting significant attention from investors, thanks to its promising financial outlook and strong market position. With..

Encompass Health Corporation (EHC) Investor Outlook: Analyzing a 39.64% Potential Upside

Encompass Health Corporation (NYSE: EHC), a major player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing opportunity for investors seeking growth in the post-acute..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is drawing significant attention from investors due to its solid product portfolio and a substantial potential upside of..

Cytokinetics (CYTK) Stock Analysis: Unveiling the 40.98% Potential Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, continues to capture the attention of investors with its bold strides in muscle activator and inhibitor therapies. With a..

argenx SE (ARGX) Stock Analysis: Exploring 26% Potential Upside Amid Robust Revenue Growth

For investors seeking opportunities in the biotechnology sector, argenx SE (NASDAQ: ARGX) presents a compelling case with its strong market position and promising growth prospects. Based in the Netherlands, this..

Inspire Medical Systems, Inc. (INSP): Stock Analysis Highlights 50% Potential Upside for Investors

Inspire Medical Systems, Inc. (NASDAQ: INSP) is capturing the attention of investors with its innovative medical solutions and significant growth prospects. As a key player in the medical devices industry,..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations

Baxter International Inc. (NYSE: BAX) presents an intriguing investment prospect for those eyeing the healthcare sector, particularly within the medical instruments and supplies industry. With a significant market presence backed..

Option Care Health, Inc. (OPCH) Stock Analysis: A Strong Growth Prospect with a 5.22% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector focusing on home and alternate site infusion services, presents a compelling opportunity for investors seeking growth in..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Contender with 8.84% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a significant player in the healthcare sector, is capturing investor attention with its robust business model and a promising price target. With its roots in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring the Biotech Firm’s 434% Revenue Growth and Future Prospects

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. With a market capitalization of $10.93 billion,..

BioNTech SE (BNTX) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to immunotherapies targeting cancer and infectious diseases. Headquartered in Mainz, Germany,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Riding the Wave of 32% Revenue Growth in the Booming Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX) has captured the attention of investors with its innovative solutions in the medical devices sector, specifically in the realm of organ transplant therapy. Headquartered in..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 160% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector, catching the attention of investors with its impressive market cap of $2.28 billion and a striking potential upside..

Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings and Nearly 20% Upside Potential

Investors searching for promising opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) an intriguing prospect. With a market capitalization of $3.2 billion, Prestige Consumer Healthcare..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking the 173% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a pioneering player in the biotechnology sector, has captured investor attention with a compelling potential upside of 173.16%, according to analyst ratings. With a market..

Masimo Corporation (MASI) Investor Outlook: Exploring a 29% Potential Upside in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors. With a market capitalization of $7.63 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds